SECURE CLOUD ACCESS
IF THERE IS NO EARLY DIAGNOSIS,
THEN
THERE IS NO TIMELY TREATMEN
T
AUTONOMIC NERVOUS SYSTEM
AND VASCULAR ASSESSMENTS
HOME
ABOUT US
PRODUCTS
TM-FLOW
ANS-1
PAD SERIES
TBL-ABI
LD-OXY
SWEATC
TECHNOLOGIES
SUGGESTED CPT CODES
STUDIES
TRUST BOARDS
PEER REVIEWS
NEWS
FAQS
SUPPORT
WARRANTY
CONTACT
LD PRODUCTS: EARLY DETECTION OF DIABETES COMPLICATIONS
AUTONOMIC NERVOUS SYSTEM AND VASCULAR FUNCTION ASSESSMENTS
BLOOD PRESSURE AND ARTERIAL STIFFNESS ANALYSIS
Monitoring and treatment.
Management of hypertension,
HEART RATE VARIABILITY (HRV)
Cardiac Autonomic Dysfunction Assessment.
PHOTOPLETHYSMOGRAPHY
Mathematical Analysis of the
pulse Ox wave.
CARDIAC AUTONOMIC REFLEX TESTs (CARTs)
Cardiac Autonomic Neuropathy Assessment.
SUDOMOTOR
FUNCTION TESTS
ANKLE BRAKIAL INDEX (ABI)
Peripheral Artery Disease (PAD).
Blood flow blockage or calcification.
Skin Microcirculation and
small fiber Assessments
MAIN SYMPTOMS OF AUTONOMIC NEUROPATHY AND VASCULAR DYSFUNCTION
FATIGUE
HEADACHE
DIZZINESS
EXERCISE INTOLERANCE
FAINTING
TINGLING IN THE TOES OR FINGERS
CLAUDICATION
PAINFUL MUSCLE CRAMPING IN THE HIPS, THIGHS OR CALVES WHEN WALKING, CLIMBING STAIRS OR EXERCING.
USA POPULATION THAT SHOULD BE TESTED BY LD TECHNOLOGY PRODUCTS
AUTONOMIC NEUROPATHY AND VASCULAR DYSFUNCTION IN THE USA.
50+
Population over 50 years old
with cardiovascular risk factors
(Hypertensive, Overweight, Smoker, Diabetic).
70+
Population over 70 years old.
OVER 45 MILLIONS PEOPLE
EVERYONE IN THE RISK GROUP SHOULD BE MEASURED WITH LD PRODUCTS
LD SOLUTIONS
COMPUTER AND LAPTOP INTERFACES
AUTONOMIC &
VASCULAR
ASSESSMENTS
NEW INTERFACES : THE PAD SERIES
ADAPTED TO THE HEALTH PROFESSIONAL NEEDS
DOWNLOAD LD PRODUCTS CATALOG